These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 194624)

  • 1. [Use of specific angiotensin inhibitors in the study of hormone-receptor interaction].
    Myshlyakova NV; Indulen YuI ; Klusha VE; Chipens GI
    Biokhimiia; 1976 Jul; 41(6):1008-13. PubMed ID: 194624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptors.
    Moore GJ; Matsoukas JM; Scanlon MN; Franklin KJ; Goghari MH
    Proc West Pharmacol Soc; 1984; 27():377-83. PubMed ID: 6093134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific antagonism between angiotensin II and several of its analogs].
    Myshliakova NV; Auna ZP; Indulen IuI; Klusha VE; Chipens GI
    Probl Endokrinol (Mosk); 1976; 22(3):85-9. PubMed ID: 935097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of action of sarmesin and sarilesin at angiotensin receptors in smooth muscle.
    Koziarz P; Moore GJ
    Proc West Pharmacol Soc; 1989; 32():79-84. PubMed ID: 2780619
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
    Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
    Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and irreversible block of the myotropic action of angiotensin II.
    Escher EH; Nguyen TM; Guillemette G; Regoli DC
    Nature; 1978 Sep; 275(5676):145-6. PubMed ID: 211425
    [No Abstract]   [Full Text] [Related]  

  • 8. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA; Weaver JM; Fink GD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon.
    Gagnon D; Park WK; Regoli D
    Br J Pharmacol; 1971 Oct; 43(2):409-10. PubMed ID: 4333805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
    Song K; Allen AM; Paxinos G; Mendelsohn FA
    J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
    de Godoy MA; de Oliveira AM; Rattan S
    J Pharmacol Exp Ther; 2004 Oct; 311(1):394-401. PubMed ID: 15178697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor.
    Bumpus FM
    Fed Proc; 1977 Jul; 36(8):2128-32. PubMed ID: 194800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prolonged low dose infusion of angiotensin II and aldosterone on rat smooth muscle and adrenal angiotensin II receptors.
    Douglas JG; Brown GP
    Endocrinology; 1982 Sep; 111(3):988-92. PubMed ID: 6286291
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Clin Sci (Lond); 2000 Oct; 99(4):331-41. PubMed ID: 10995600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin receptors].
    Sirakova I; Sirakov L
    Eksp Med Morfol; 1981; 20(3):125-9. PubMed ID: 6273115
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptors for angiotensin II and III in rat adrenals.
    Devynck MA; Koreve V; Matthews PG; Meyer P; Pernollet MG
    Adv Nephrol Necker Hosp; 1977; 7():121-135. PubMed ID: 208406
    [No Abstract]   [Full Text] [Related]  

  • 19. The contribution of the N-terminal region of angiotensin II antagonists to receptor binding.
    Ganter RC; Goghari MH; Moore GJ
    Proc West Pharmacol Soc; 1987; 30():113-6. PubMed ID: 3628261
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
    Barki-Harrington L; Luttrell LM; Rockman HA
    Circulation; 2003 Sep; 108(13):1611-8. PubMed ID: 12963634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.